rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
13
|
pubmed:dateCreated |
2009-4-30
|
pubmed:abstractText |
The improvement of Ewing sarcoma (EWS) therapy is currently linked to the discovery of strategies to select patients with poor and good prognosis and of modified treatment regimens. In this study, we analyzed the molecular factors governing EWS response to chemotherapy to identify genetic signatures to be used for risk-adapted therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:CaccuriAnna MariaAM,
pubmed-author:CantianiLaraL,
pubmed-author:CastellaniGastoneG,
pubmed-author:FrancesconiMirkoM,
pubmed-author:KnuutilaSakariS,
pubmed-author:ManaraMaria CristinaMC,
pubmed-author:MercuriMarioM,
pubmed-author:NardiFilippoF,
pubmed-author:PicciPieroP,
pubmed-author:RemondiniDanielD,
pubmed-author:ScotlandiKatiaK,
pubmed-author:SerraMassimoM
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2209-16
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:19307502-Antineoplastic Agents,
pubmed-meshheading:19307502-Bone Neoplasms,
pubmed-meshheading:19307502-Cell Line, Tumor,
pubmed-meshheading:19307502-Drug Resistance, Neoplasm,
pubmed-meshheading:19307502-Female,
pubmed-meshheading:19307502-Gene Expression Profiling,
pubmed-meshheading:19307502-Glutathione S-Transferase pi,
pubmed-meshheading:19307502-Glutathione Transferase,
pubmed-meshheading:19307502-Humans,
pubmed-meshheading:19307502-Male,
pubmed-meshheading:19307502-Oxadiazoles,
pubmed-meshheading:19307502-Principal Component Analysis,
pubmed-meshheading:19307502-Prognosis,
pubmed-meshheading:19307502-Sarcoma, Ewing
|
pubmed:year |
2009
|
pubmed:articleTitle |
Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome.
|
pubmed:affiliation |
Laboratory of Oncologic Research, Orthopaedic Institute Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy. katia.scotlandi@ior.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|